MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

02 Feb 2022 Evaluate
The company witnessed a 8.80% growth in the revenue at Rs. 129.20 millions for the quarter ended December 2021 as compared to Rs. 118.75 millions during the year-ago period.Net Profit of the company move down -39.12% to Rs. 13.71  millions from Rs. 22.52 millions  in the same quarter last year.Operating profit for the quarter ended December 2021 rose to 57.54 millions as compared to 47.84 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 129.20 118.75 8.80 360.85 356.94 1.10 517.75 553.52 -6.46
Other Income 0.00 0.00 0.00 2.44 0.00 0.00 0.79 0.53 49.06
PBIDT 57.54 47.84 20.28 144.52 136.57 5.82 177.43 125.24 41.67
Interest 12.04 5.43 121.73 31.28 22.77 37.37 35.29 30.98 13.91
PBDT 45.50 42.41 7.29 113.24 113.80 -0.49 142.14 94.26 50.80
Depreciation 17.10 13.15 30.04 52.36 38.38 36.43 55.91 51.72 8.10
PBT 28.40 29.26 -2.94 60.88 75.42 -19.28 86.23 42.54 102.70
TAX 14.69 6.74 117.95 32.09 21.58 48.70 29.37 -1.89 -1653.97
Deferred Tax 10.31 -3.64 -383.24 19.63 1.97 896.45 15.79 -13.11 -220.44
PAT 13.71 22.52 -39.12 28.79 53.84 -46.53 56.86 44.43 27.98
Equity 142.05 128.88 10.22 142.05 128.88 10.22 134.19 128.88 4.12
PBIDTM(%) 44.54 40.29 10.55 40.05 38.26 4.67 34.27 22.63 51.46
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..